Wed 26th Aug 2026 | Posted by Melissa Wright, on General, News,

The United States District Court for the District of New Jersey has granted final approval to a $9,500,000 all-cash settlement resolving securities fraud claims brought on behalf of investors who purchased Eagle Pharmaceuticals, Inc. (formerly NASDAQ: EGRX) common stock. Glancy Prongay Wolke & Rotter LLP served as Court-appointed Lead Counsel for the certified Settlement Class. The Honorable Michael A. Hammer, United States Magistrate Judge, entered judgment approving the settlement on August 19, 2026. Carella, Byrne, Cecchi, Brody & Agnello, P.C. served as Liaison Counsel. The action was prosecuted on behalf of Court-appointed lead plaintiff Evans Associates I, LLC and named […]